HOME >> MEDICINE >> NEWS
Unique vascular dysfunction in women's heart disease described in major journal supplement

ported activities of daily living. These are translated into METs (metabolic equivalents), which are used to approximate physical work capacity. Two-thirds of the cardiac events in the WISE women occurred in those with an estimated capacity of less than 4.7 DASI METs. Women with evidence of lower scores were also significantly more likely to have risk factors and obstructive coronary artery disease.

  • Overweight women are more likely than normal weight women to have coronary artery disease risk factors. But the WISE researchers found that the issue is not obesity alone. Instead, it appears that the metabolic alterations associated with obesity are key factors in placing a woman at risk for CAD and cardiac events. Women with the "metabolic syndrome" are at much higher risk of cardiac events than those with a normal metabolic status. The metabolic syndrome includes insulin resistance, unhealthy cholesterol and/or triglyceride levels, hypertension, and abdominal obesity.
  • The recognition of different, unique risk factors for IHD in women such as inflammatory processes in the arteries, anemia and microvascular dysfunction leads to the possibility that different diagnostic and prognostic tools may be employed. Among options currently being evaluated are high-sensitivity C-reactive protein (a laboratory test that can detect inflammatory processes), hemoglobin monitoring, and retinal artery narrowing examinations and coronary calcification tests (for detection of atherosclerosis).

  • '"/>

    Contact: Sandy Van
    sandy@prpacific.com
    800-880-2397
    Cedars-Sinai Medical Center
    3-Feb-2006


    Page: 1 2 3

    Related medicine news :

    1. Unique laboratory could make pavements more user-friendly
    2. Unique results from Swedish study of HIV vaccine
    3. No butts about it: Unique UH database shows Texas is crushing out smoking
    4. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
    5. Pot bellies linked to early signs of cardiovascular disease
    6. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
    7. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
    8. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
    9. Womens mortality rates for cardiovascular disease differ widely among hospitals
    10. Study explains why patients with OSA are at higher risk for cardiovascular disease
    11. Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:7/21/2017)... ... July 21, 2017 , ... ... years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could ... after surgery, though activity levels decline over time. The study, presented today at ...
    (Date:7/21/2017)... , ... July 21, 2017 , ... ... why concussion rates are on the rise, say researchers presenting their work at ... Toronto, Ontario, Canada. , “The combination of evaluating the patterns of change in ...
    (Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
    (Date:7/20/2017)... NY, July 20, 2017 (PRWEB) , ... ... ... Nastel Technologies, a global provider of enterprise-grade IT operations analytics and application ... arm of one of world’s largest healthcare services providers. , According to ...
    (Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
    Breaking Medicine News(10 mins):
    (Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... a clinical-stage pharmaceutical company focused on the development of oral ... from the Israel Securities Authority to dual-list its common stock ... will commence trading on the TASE on July 12, 2017 ... of the Company, it is expected that Oramed will be ...
    (Date:7/5/2017)... Wash. , July 5, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... cryopreservation freeze media ("BioLife"), today announced that it ... its debt holder and largest shareholder, to modify its ... Pursuant to the modification, WAVI agreed to exchange ...
    (Date:6/30/2017)... In vitro diagnostics market firm Kalorama Information ... least ten diagnostic companies have successfully completed financings.  The ... a loan facility.  The size of these financings ranged ... Information provides a monthly IVD Market Trends Report ... "Diagnostics deals ...
    Breaking Medicine Technology:
    Cached News: